Risk of Herpes Zoster in Patients Receiving Anti-TNF-α in the Prospective French RATIO Registry

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of investigative dermatology 2012-03, Vol.132 (3), p.726-729
Hauptverfasser:	Serac, Gaelle, Tubach, Florence, Mariette, Xavier, Salmon-Céron, Dominique, Ravaud, Philippe, Lioté, Frederic, Laharie, David, Ziza, Jean-Marc, Marguerie, Laurent, Bonnet, Christine, Falgarone, Geraldine, Nicolas, Nathalie, Lortholary, Olivier, Chosidow, Olivier
Format:	Artikel
Sprache:	eng
Schlagworte:	Adalimumab Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Antirheumatic Agents - administration & dosage Antirheumatic Agents - adverse effects Biological and medical sciences Case-Control Studies Dermatology Etanercept Female France - epidemiology Herpes Zoster - epidemiology Herpes Zoster - etiology Human viral diseases Humans Immunoglobulin G - administration & dosage Immunoglobulin G - adverse effects Infectious diseases Infliximab Male Medical sciences Middle Aged Prospective Studies Receptors, Tumor Necrosis Factor - administration & dosage Risk Severity of Illness Index Treatment Outcome Tumor Necrosis Factor-alpha - antagonists & inhibitors Viral diseases Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!